从视野到精准:子宫内膜异位症手术术中导航技术的系统综述
该研究系统检索了2015至2025年PubMed/MEDLINE、Embase和Scopus数据库,纳入54项研究共1002例患者,评估子宫内膜异位症手术中术中导航技术的临床证据。结果显示术中光学成像(41项,976例)和术中超声(12项,24例)是主要导航方式,增强/虚拟现实仅1项病例系列(2例),证据仍有限,需前瞻性比较研究明确适应证与附加价值。
要点
- 术中光学成像特别是吲哚菁绿引导手术是报道最多的导航方式,支持解剖定向与病灶评估。
- 术中超声有助于病灶定位与标志点界定,但纳入患者数较少。
- 增强/虚拟现实仍处于临床转化早期,现有证据不足以确定其临床价值。
核心结论
- 术中光学成像(尤其吲哚菁绿引导手术)和术中超声是目前子宫内膜异位症手术中主要报道的导航方式,支持实时解剖定向和术中决策,而增强/虚拟现实应用仍处于早期临床转化阶段。
- 尽管盆腔解剖复杂且疾病表现异质,当前证据仍然有限,需要前瞻性比较研究来确定这些技术的临床适应证和附加价值。
研究设计与样本
- 遵循PRISMA指南的系统综述,检索PubMed/MEDLINE、Embase和Scopus数据库2015至2025年文献,最终检索于2025年9月10日执行,并辅以AI辅助平台补充检索。
- 纳入标准为报告术中导航技术的人体手术研究,排除临床前和尸体研究、无术中应用报告及缺乏导航成分的干预;仅纳入英文文献,不限研究设计。
- 由两名独立评审员进行研究筛选和全文评估,分歧通过共识解决;从800条记录中最终纳入54项研究,共1002例患者。
主要发现
- 纳入的54项研究中,术中光学成像研究41项(976例患者),术中超声研究12项(24例患者),增强/虚拟现实病例系列1项(2例患者)。
- 术中光学成像主要支持解剖定向、病灶评估和灌注相关决策;术中超声支持病灶定位和标志点界定;增强/虚拟现实支持术前三维规划并用于术中。
关键数值与推荐
- 共纳入54项研究、1002例患者:术中光学成像41项(976例)、术中超声12项(24例)、增强/虚拟现实1项(2例)。
- 检索时间范围为2015至2025年,最终检索日期为2025年9月10日;从800条记录中筛选出54项符合标准的研究。
临床怎么用
- 在复杂盆腔子宫内膜异位症手术中,可考虑使用术中光学成像(如吲哚菁绿引导)和术中超声辅助实时解剖定向与术中决策。
- 增强/虚拟现实技术目前证据有限,临床应用应限于研究或早期探索场景。
局限性
- 当前证据仍然有限,研究设计异质且多为非比较性研究,增强/虚拟现实仅基于1项2例的病例系列。
- 需要前瞻性比较研究来确定这些导航技术的临床适应证和附加价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To systematically evaluate the clinical evidence on intraoperative navigation techniques in endometriosis surgery. DATA SOURCES: In accordance with the PRISMA guidelines, a systematic literature search was conducted in the databases PubMed/MEDLINE, Embase, and Scopus covering the period from 2015 to 2025, with the final search performed on September 10th, 2025. In addition, an AI-assisted platform was used as a complementary search tool to identify further relevant literature. METHODS OF STUDY SELECTION: Eligible studies comprised surgical studies in humans reporting intraoperative navigation techniques. Preclinical and cadaveric studies, reports without intraoperative applications, and interventions lacking a navigation component were excluded. Abstracts were excluded unless intraoperative data were extractable. Only English-language publications were included, with no restrictions on study design. Study selection was conducted by two independent reviewers followed by full-text assessment, with discrepancies resolved by consensus. TABULATION, INTEGRATION, AND RESULTS: A standardized template captured design, sample size, navigation modality, technical parameters, approach, workflow integration, and outcomes; quality appraisal used design-specific tools. From 800 records, 54 studies (1,002 patients) met inclusion criteria: 41 intraoperative optical imaging studies (IOI) (976 patients), 12 intraoperative ultrasound studies (IOUS) (24 patients), and 1 augmented/virtual reality (AR/VR) case series (2 patients). IOI mainly supported anatomic orientation, lesion assessment, and perfusion-related decisions; IOUS supported lesion localization and landmark definition; AR/VR supported preoperative 3D planning which was used intraoperatively. CONCLUSION: In endometriosis surgery, IOI, particularly indocyanine green-guided surgery, and IOUS currently constitute the predominant reported navigation modalities, supporting real-time anatomical orientation and informed intraoperative decision-making in complex pelvic disease, while AR/VR applications remain at an early stage of clinical translation. Despite the challenging pelvic anatomy and heterogenous disease manifestations that could benefit from intraoperative navigation, current evidence remains limited. Prospective comparative studies are needed to define clinical indications and to determine the added value of these technologies.
引用
- Inci A, Andress J, Kraemer B, et al. From Vision to Precision: A Systematic Review of Intraoperative Navigation Techniques in Endometriosis Surgery. J Minim Invasive Gynecol. 2026. PMID: 41831712. doi:10.1016/j.jmig.2026.03.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。